Enquiry IconContact Us
CMI Logo

Small Cell Lung Cancer (SCLC) is malignant form of cancer arising within the lungs. SCLC is characterized by high growth rate, shorter doubling time than the non-small cell lung tumors. SCLC is more responsive to chemotherapy than NSCLC. Small cell lung cancer is highly associated with tobacco, unhealthy food, alcohol, HIV infected, chronic infections or related family history, and physical inactivity. The decrease in smoking is reflected as the substantial decrease in the incidence of SCLC. The symptoms include dyspnea, blood in sputum, weight loss, cough, and debility.

Global rise in number of cancer cases expected to support the growth of small cell lung cancer therapeutics market in the near future

According to the American Cancer Society Statistics in 2016, maximum cases of SCLC occur in individuals aged 60-80 years with an estimated global death rate being 30,000 per year. Also, according to the World Health Organization (WHO), lung cancer is the second most prevailing cancer in men and women causing 1.59 million deaths in 2012. The rising prevalence of lung cancer, rise in unhealthy lifestyle, the launch of innovative radiation therapies, and premium priced drugs are the major factors driving the growth of lung cancer therapeutics market. Additionally, rising demand for targeted therapies and platinum-based chemotherapies is likely to have an optimistic impact on the small lung cancer therapeutics market in the forecast period. Also, increasing diagnostic facilities by the government, provision of guidelines to cancer patients by International Healthcare Organizations are the major factors contributing to the rising of small cell lung cancer market. However, expensive treatments, lack of awareness leading to late diagnosis are the major factors restraining the small cell lung cancer market growth.

Platinum derivatives segment accounts for highest revenue share owing to the higher metastasis control rate

The global small cell lung cancer therapeutics market is segmented on the basis of drug therapy, and distribution channel.

On the basis of drug therapy, the global small cell lung cancer therapeutics market is segmented into:

  • Targeted Therapy Drugs
  • Immunotherapy Drugs
  • Platinum Derivatives

On the basis of distribution channel, the global small cell lung cancer therapeutics market is segmented into:

  • Hospital Pharmacies
  • Retail and Online Pharmacies

Enhanced health care dynamics to boost the Asia Pacific small cell lung cancer market

Regional segmentation of small cell lung cancer therapeutics market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. According to the American Cancer Society Statistics in 2017, around 222,500 cases of lung cancer were diagnosed with 116,990 prevailing in men and 105,510 in women, where small cell lung cancer accounts for 15 percent of lung cancers in the U.S. North America is expected to dominate the market owing to the high developed regions, improved healthcare setup, and growing awareness about healthcare. Asia Pacific is expected to drive the growth of SCLC market in the forecast period owing to the growing awareness of health care, government funding, and the presence of medical requirements for cancer therapeutics in the emerging economies such as India and China.

Key players in the Small Cell Lung Cancer Therapeutics Market

Key players operating the small cell lung cancer therapeutics market include Bristol-Myers Squibb, GlaxoSmithKline, Menarini, Sanofi, and ZIOPHARM Oncology.  


Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Subscribe Newsletter

Kindly subscribe for our latest news & articles.